Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2014
08/26/2014US8816049 Lipid peptide and hydrogel
08/26/2014US8816047 Compositions and methods of using proislet peptides and analogs thereof
08/26/2014US8816046 Compositions and methods for CaMKII inhibitors and uses thereof
08/26/2014US8815913 Metal-catalyzed copolymerization of imines and carbon monoxide as a route to synthesize polypeptides
08/26/2014US8815874 Pyrazolopyrimidine derivative
08/26/2014US8815858 Heterocyclic flaviviridae virus inhibitors
08/26/2014US8815823 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
08/26/2014US8815814 Cosmetic composition containing oligopeptides
08/26/2014US8815813 Methods for treating immune-mediated Dengue Fever infections and antibody-dependent enhancement of Dengue Fever infections, including Dengue Hemorrhagic Fever and Dengue Shock Syndrome
08/26/2014US8815812 Synthetic arginine substituted peptides and their use
08/26/2014US8815811 Peptides and methods for their preparation and use
08/26/2014US8815810 Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
08/26/2014US8815809 Cysteine protease inhibitors
08/26/2014US8815808 Modulation of activity of neurotrophins
08/26/2014US8815807 Peptides and peptide compositions having osteoinductive activity
08/26/2014US8815806 Yellow pea seed protein-derived peptides
08/26/2014US8815805 Formulations having an antagonist of α5β1 for anti-angiogenesis and cancer treatment
08/26/2014US8815804 Methods and compositions related to targeting tumors and wounds
08/26/2014US8815803 Method for increasing body height comprising systemic administration of CNP-53
08/26/2014US8815802 GLP-1 analogues and derivatives
08/26/2014US8815801 Controlled release composition and method of producing the same
08/26/2014US8815796 Polyheterocyclic compounds highly potent as HCV inhibitors
08/26/2014US8815795 Methods for preventing or treating eye diseases using adiponectin
08/26/2014US8815794 Treatment of amyloidoses using myelin basic protein and fragments thereof
08/26/2014US8815793 Polymeric compositions and related methods of use
08/26/2014US8815580 Cells producing glycoproteins having altered glycosylation patterns and method and use thereof
08/26/2014US8815544 Production of galactosylated glycoproteins in lower eukaryotes
08/26/2014US8815511 Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
08/26/2014US8815503 Compositions and methods for immunostimulatory RNA oligonucleotides
08/26/2014US8815320 Process for producing a composition containing active follistatin
08/26/2014US8815299 Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds
08/26/2014US8815295 Anti respiratory syncytial virus peptide functionalized gold nanoparticles
08/26/2014US8815266 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails
08/26/2014US8815261 Composition for external application comprising aripiprazole and organic acid as active ingredients
08/26/2014US8815250 Clotting factor-Fc chimeric proteins to treat hemophilia
08/26/2014US8815249 Ii-key/antigenic epitope hybrid peptide vaccines
08/26/2014US8815238 Methods for Preparing TACI-immunoglobulin fusion proteins
08/26/2014US8815234 Treatment of human or animal body surface infection
08/26/2014US8815233 Method for treating pervasive development disorders
08/26/2014US8815232 Compositions and methods for treating cancer
08/26/2014US8815230 Methods for treating Friedreich's ataxia with interferon gamma
08/26/2014US8815229 Granulysin in immunotherapy
08/26/2014US8815226 Protein-polymer-drug conjugates
08/26/2014US8815214 Fluorescent imaging agents
08/26/2014CA2691539C Modified toxins
08/26/2014CA2672284C Human growth hormone formulations
08/26/2014CA2615666C Novel macrocyclic inhibitors of hepatitis c virus replication
08/26/2014CA2523620C Drug releasing biodegradable fiber for delivery of therapeutics
08/26/2014CA2467309C Type iii secretion pathway in aeromonas salmonicida, and uses therefor
08/26/2014CA2407784C Treatment of acute coronary syndrome with glp-1
08/26/2014CA2390344C 85kda neisserial antigen
08/21/2014WO2014127316A2 Proprotein convertase subtilisin/kexin type 9 (pcsk9) allosteric binding ligands to mudulate serum low density lipoprotein (ldl) levels
08/21/2014WO2014127211A1 Deimmunized gelonin molecules and therapies
08/21/2014WO2014127120A1 Insulin secreting polypeptides
08/21/2014WO2014127112A1 Memory enhancer and actin dynamics
08/21/2014WO2014127007A1 Ophthalmic formulation derived from silk protein
08/21/2014WO2014126997A1 Glaucoma treatment
08/21/2014WO2014126965A2 Compositions and methods for treating pathological calcification and ossification
08/21/2014WO2014126902A1 Kit for tumor imaging
08/21/2014WO2014126828A1 Novel ph-switchable peptides for membrane insertion and pore formation
08/21/2014WO2014126787A1 Methods for increasing n-glycan occupancy and reducing production of hybrid n-glycans in pichia pastoris strains lacking alg3 expression
08/21/2014WO2014126681A1 Short bio-active peptides for promoting wound healing
08/21/2014WO2014126594A1 Treatment of evolving bacterial resistance diseases including klebsiella pneumoniae with liposomally formulated glutathione
08/21/2014WO2014126582A1 IL-1β INHIBITOR COMPOSITION AND USE THEREOF
08/21/2014WO2014125291A1 Agents which induce lymphangiogenesis for use in the treatment of cystic kidney disease
08/21/2014WO2014125290A1 Scaffold proteins derived from plant cystatins
08/21/2014WO2014125110A1 Abhd5 and partial hdac4 fragments and variants as therapeutic approach for the treatment of cardiovascular diseases
08/21/2014WO2014124540A1 Modified ingap peptides for treating diabetes
08/21/2014WO2014124487A1 Ligand binding molecules and uses thereof
08/21/2014WO2014113431A3 Methods and compositions for targeting immunoglobulins
08/21/2014WO2014102755A4 Bortezomib formulations
08/21/2014WO2014102596A3 Cyclic cationic peptides with antibmicrobial activity
08/21/2014WO2014100755A3 Formulations and methods for stabilizing pcr reagents
08/21/2014WO2014071405A3 Long-acting single-chain insulin analogues
08/21/2014US20140237632 Rapidly maturing fluroscent proteins and methods for using the same
08/21/2014US20140235844 Short Interfering RNA (siRNA) Analogues
08/21/2014US20140235832 Rank ligand polypeptides
08/21/2014US20140235829 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
08/21/2014US20140235819 Deuterated Cyclosporine Analogs and Methods of Making the Same
08/21/2014US20140235597 Ophthalmologic Irrigation Solutions and Method
08/21/2014US20140235556 Compositions and methods of treating gliomas
08/21/2014US20140235555 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons
08/21/2014US20140235554 Ophthalmic formulation derived from silk protein
08/21/2014US20140235552 Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent
08/21/2014US20140235548 Compositions and methods for jamm protein inhibition
08/21/2014US20140235547 In Vivo Synthesis of Elastic Fiber
08/21/2014US20140235544 Disease treatment via antimicrobial peptides or their inhibitors
08/21/2014US20140235542 Modular, bioactive peptides for binding native bone and improving bone graft osteoinductivity
08/21/2014US20140235541 Compositions and methods for treatment of aortic fibrosis
08/21/2014US20140235540 Androgen and gonadotropin treatment in females
08/21/2014US20140235536 Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicals
08/21/2014US20140235534 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
08/21/2014US20140235532 Immunogenic escherichia coli heat stable enterotoxin
08/21/2014US20140235531 Antimicrobial peptides for treatment of infectious diseases
08/21/2014US20140235530 Spray Drying Vancomycin
08/21/2014US20140235528 Inhibiting gs-fdh to modulate no bioactivity
08/21/2014US20140235527 Composition for treatment or prevention of erectile dysfunction including dkk2 protein or dkk2 gene thereof and use of the composition
08/21/2014US20140235526 Methods for Generating Cardiomyocytes
08/21/2014US20140234945 Transthyretin variants
08/21/2014US20140234902 Methods for producing modified glycoproteins
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 3163